These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease]. Sin DD; Wu L; Anderson JA; Anthonisen NR; Buist A; Burge PS; Calverley PM; Connett JE; Lindmark B; Pauwels RA Rev Port Pneumol; 2005; 11(6):603-7. PubMed ID: 16518885 [No Abstract] [Full Text] [Related]
10. Weighing the benefits and risks of inhaled corticosteroids. Varkey B Curr Opin Pulm Med; 2007 Mar; 13(2):89. PubMed ID: 17255797 [No Abstract] [Full Text] [Related]
11. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304 [TBL] [Abstract][Full Text] [Related]
12. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis. Cave AC; Hurst MM Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815 [TBL] [Abstract][Full Text] [Related]
13. Inhaled corticosteroids in COPD: the case against. Suissa S; Barnes PJ Eur Respir J; 2009 Jul; 34(1):13-6. PubMed ID: 19567599 [No Abstract] [Full Text] [Related]
14. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD. Joo MJ; Au DH; Fitzgibbon ML; Lee TA Respir Med; 2010 Feb; 104(2):246-52. PubMed ID: 19879745 [TBL] [Abstract][Full Text] [Related]
15. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Singh S; Amin AV; Loke YK Arch Intern Med; 2009 Feb; 169(3):219-29. PubMed ID: 19204211 [TBL] [Abstract][Full Text] [Related]
16. Inhaled corticosteroids and mortality in COPD: are we there yet? Stirling R Thorax; 2006 Aug; 61(8):735. PubMed ID: 16877693 [No Abstract] [Full Text] [Related]
17. Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids? Festic E; Scanlon PD Am J Respir Crit Care Med; 2015 Jan; 191(2):141-8. PubMed ID: 25409118 [TBL] [Abstract][Full Text] [Related]
18. Risk of pneumonia with use of inhaled corticosteroids in patients with chronic obstructive pulmonary disease. Singh V; Kanvaria P Indian J Chest Dis Allied Sci; 2010; 52(4):195-6. PubMed ID: 21302594 [No Abstract] [Full Text] [Related]
19. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease. Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915 [TBL] [Abstract][Full Text] [Related]
20. [Inhaled steroids and COPD mortality: limitation of epidemiological analysis of databases]. Gillissen A; Lewis M; Worth H Pneumologie; 2003 Nov; 57(11):639-42. PubMed ID: 14618505 [No Abstract] [Full Text] [Related] [Next] [New Search]